DENAS, GENTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.959
AS - Asia 1.543
EU - Europa 855
SA - Sud America 394
AF - Africa 353
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 22
Totale 7.152
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.801
SG - Singapore 581
CN - Cina 338
BR - Brasile 253
VN - Vietnam 137
HK - Hong Kong 133
DE - Germania 121
IT - Italia 89
SE - Svezia 83
FI - Finlandia 78
NL - Olanda 50
GB - Regno Unito 45
RU - Federazione Russa 43
PL - Polonia 42
AR - Argentina 34
JP - Giappone 30
FR - Francia 29
CI - Costa d'Avorio 28
BE - Belgio 22
IN - India 22
AT - Austria 20
IQ - Iraq 20
EC - Ecuador 19
ZA - Sudafrica 19
CO - Colombia 18
CA - Canada 17
MX - Messico 17
IE - Irlanda 16
TR - Turchia 16
UA - Ucraina 16
ES - Italia 15
PY - Paraguay 15
CZ - Repubblica Ceca 14
EG - Egitto 14
ID - Indonesia 14
VE - Venezuela 14
RO - Romania 13
BA - Bosnia-Erzegovina 12
CY - Cipro 12
LA - Repubblica Popolare Democratica del Laos 12
MD - Moldavia 12
MG - Madagascar 12
MW - Malawi 12
NP - Nepal 12
PA - Panama 12
PK - Pakistan 12
UZ - Uzbekistan 12
BY - Bielorussia 11
CM - Camerun 11
DO - Repubblica Dominicana 11
KE - Kenya 11
KG - Kirghizistan 11
MA - Marocco 11
ML - Mali 11
PE - Perù 11
SO - Somalia 11
TJ - Tagikistan 11
TW - Taiwan 11
XK - ???statistics.table.value.countryCode.XK??? 11
BJ - Benin 10
CL - Cile 10
CU - Cuba 10
GR - Grecia 10
JO - Giordania 10
KZ - Kazakistan 10
MZ - Mozambico 10
PH - Filippine 10
PT - Portogallo 10
SA - Arabia Saudita 10
SN - Senegal 10
YE - Yemen 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CH - Svizzera 9
DJ - Gibuti 9
HN - Honduras 9
IL - Israele 9
LB - Libano 9
MY - Malesia 9
TN - Tunisia 9
UY - Uruguay 9
YT - Mayotte 9
AM - Armenia 8
AO - Angola 8
BG - Bulgaria 8
DZ - Algeria 8
GM - Gambi 8
GN - Guinea 8
GP - Guadalupe 8
JM - Giamaica 8
RW - Ruanda 8
TZ - Tanzania 8
ZW - Zimbabwe 8
BF - Burkina Faso 7
BW - Botswana 7
CR - Costa Rica 7
CV - Capo Verde 7
ET - Etiopia 7
GF - Guiana Francese 7
GH - Ghana 7
Totale 6.844
Salva come PNG Salva come JPEG
Città #
Fairfield 613
Ashburn 462
Singapore 320
Woodbridge 319
Chandler 318
Ann Arbor 243
Houston 239
Cambridge 233
Seattle 197
Wilmington 185
Hong Kong 127
Beijing 120
Santa Clara 79
Boardman 68
San Diego 50
Princeton 48
Munich 47
Medford 45
Los Angeles 42
Des Moines 40
Helsinki 37
Ho Chi Minh City 35
New York 33
Bytom 32
Nanjing 29
Abidjan 28
Dong Ket 27
Frankfurt am Main 26
Padova 21
Hanoi 19
Redondo Beach 18
Roxbury 17
Tokyo 15
Chicago 14
Dublin 14
Buffalo 13
Nanchang 12
Panama City 12
Shenyang 12
Bamako 11
Cairo 11
Vienna 11
Vientiane 11
Antananarivo 10
Bishkek 10
Brussels 10
Dakar 10
Dushanbe 10
Guangzhou 10
Johannesburg 10
Tashkent 10
Turku 10
Amman 9
Baghdad 9
Baku 9
Cotonou 9
Hefei 9
London 9
Minsk 9
Pristina 9
Stockholm 9
Warsaw 9
Conakry 8
Dar es Salaam 8
Falkenstein 8
Guayaquil 8
Harare 8
Havana 8
Kigali 8
Maputo 8
Nuremberg 8
São Paulo 8
Yerevan 8
Addis Ababa 7
Athens 7
Belo Horizonte 7
Boston 7
Chisinau 7
Denver 7
Falls Church 7
Gaborone 7
Lilongwe 7
Lima 7
Luanda 7
Montevideo 7
Nairobi 7
Zhengzhou 7
Bangkok 6
Castries 6
Chennai 6
Dearborn 6
Djibouti 6
Douala 6
Goiânia 6
Hebei 6
Istanbul 6
Jinan 6
Limassol 6
Mamoudzou 6
Milan 6
Totale 4.697
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 255
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 213
Diagnosis and therapy of antiphospholipid syndrome 204
Laboratory testing for antiphospholipid syndrome 203
Antiphospholipid syndrome and the heart: A case series and literature review 200
APS - Diagnostics and challenges for the future 198
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 197
Dyspnoea in a young woman: the opposite of every truth is just as true 193
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 186
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 184
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation 181
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome. 179
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 178
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 171
An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation 171
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 170
One-Year Outcomes After Transapical Echocardiography-Guided Mitral Valve Repair 170
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study 166
The Paradox of the Lupus Anticoagulant: History and Perspectives 166
A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures 165
Interpretation of laboratory data and need for reference laboratories. 161
The benefit of betrixaban for the extended thromboprophylaxis in acutely ill medical patients 160
Correct laboratory approach to APS diagnosis and monitoring 157
An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions 157
Laboratory Diagnostics of Antiphospholipid Syndrome 156
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation 155
Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy 152
Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective 148
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study 144
Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis 144
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 142
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma 137
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome: a nationwide survey 136
To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort 136
Reference values for 3D echo parameters describing left ventricular mechanics obtained by vendor-independent software 136
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study 135
Secondary prevention in thrombotic antiphospholipid syndrome. 134
Relationship of 3D left ventricular mass with systolic and diastolic function indices in hypertrophic cardiomyopathy 134
Optimizing quality care for the oral vitamin K antagonists (VKAs) 128
Normal left ventricular mechanics by two-dimensional speckle-tracking echocardiography. Reference values in healthy adults 126
The role of platelets in antiphospholipid syndrome 123
Reference values of right ventricular longitudinal strain by speckle tracking echocardiography in 219 healthy volunteers 119
Investigational anticoagulants for hematological conditions: a new generation of therapies 118
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure. 113
Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study 111
Totale 7.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.486
article - articoli 22.486
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.972
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021312 0 0 0 0 0 36 23 40 73 24 47 69
2021/2022713 40 70 89 52 17 48 41 80 29 16 59 172
2022/2023557 116 67 15 74 84 63 2 40 53 4 33 6
2023/2024218 7 34 25 22 7 34 14 27 5 5 19 19
2024/20251.170 6 81 72 47 139 14 93 103 83 30 192 310
2025/20262.276 243 374 543 674 440 2 0 0 0 0 0 0
Totale 7.212